全文获取类型
收费全文 | 61112篇 |
免费 | 5839篇 |
国内免费 | 1339篇 |
专业分类
耳鼻咽喉 | 713篇 |
儿科学 | 3126篇 |
妇产科学 | 613篇 |
基础医学 | 6297篇 |
口腔科学 | 1066篇 |
临床医学 | 5756篇 |
内科学 | 7707篇 |
皮肤病学 | 703篇 |
神经病学 | 3236篇 |
特种医学 | 864篇 |
外国民族医学 | 3篇 |
外科学 | 3389篇 |
综合类 | 9432篇 |
现状与发展 | 5篇 |
一般理论 | 2篇 |
预防医学 | 9752篇 |
眼科学 | 658篇 |
药学 | 4856篇 |
60篇 | |
中国医学 | 8843篇 |
肿瘤学 | 1209篇 |
出版年
2024年 | 177篇 |
2023年 | 1219篇 |
2022年 | 1854篇 |
2021年 | 3766篇 |
2020年 | 3169篇 |
2019年 | 2518篇 |
2018年 | 2453篇 |
2017年 | 2547篇 |
2016年 | 2631篇 |
2015年 | 2354篇 |
2014年 | 4461篇 |
2013年 | 4692篇 |
2012年 | 3780篇 |
2011年 | 3923篇 |
2010年 | 2996篇 |
2009年 | 2537篇 |
2008年 | 2442篇 |
2007年 | 2510篇 |
2006年 | 2102篇 |
2005年 | 1780篇 |
2004年 | 1580篇 |
2003年 | 1507篇 |
2002年 | 1114篇 |
2001年 | 1068篇 |
2000年 | 883篇 |
1999年 | 789篇 |
1998年 | 660篇 |
1997年 | 581篇 |
1996年 | 528篇 |
1995年 | 561篇 |
1994年 | 489篇 |
1993年 | 397篇 |
1992年 | 379篇 |
1991年 | 338篇 |
1990年 | 337篇 |
1989年 | 291篇 |
1988年 | 282篇 |
1987年 | 261篇 |
1986年 | 225篇 |
1985年 | 339篇 |
1984年 | 277篇 |
1983年 | 213篇 |
1982年 | 249篇 |
1981年 | 198篇 |
1980年 | 167篇 |
1979年 | 144篇 |
1978年 | 128篇 |
1977年 | 89篇 |
1976年 | 97篇 |
1975年 | 50篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
目的观察重灸中脘穴对脾胃虚寒型2型糖尿病胃轻瘫患者胃肠激素、胃动力学的影响。方法选取符合纳入标准的88例脾胃虚寒型糖尿病胃轻瘫患者,按随机数字表法分为治疗组和对照组,每组44例。对照组采用常规药物治疗,治疗组采用重灸中脘穴治疗。疗程结束后记录并对比分析两组临床疗效、胃肠激素[胃泌素(GAS)、胃动素(MTL)]、胃动力学(胃收缩频率、胃排空时间、胃排空率)、主要临床症状评分等变化。结果治疗组临床疗效明显优于对照组,差异具有统计学意义(P<0.05);两组治疗后GAS、MTL均明显优于治疗前(P<0.05),且治疗组明显优于对照组(P<0.05);两组治疗后胃收缩频率、胃排空时间、胃排空率均明显优于治疗前(P<0.05),且治疗组明显优于对照组(P<0.05);两组治疗后主要临床症状评分均明显优于治疗前(P<0.05),且治疗组明显优于对照组(P<0.05)。结论在常规药物治疗基础上重灸中脘穴治疗脾胃虚寒型2型糖尿病胃轻瘫,可调节胃肠激素,改善胃肠动力,促进胃肠功能恢复。 相似文献
62.
目的:探讨美托洛尔(β1受体阻滞剂)用于老年COPD合并冠心病史治疗的临床疗效。方法:选取2018年6月—2019年6月在我院接受治疗的60岁以上(包括60岁)COPD合并冠心病史老年患者,分为对照组与观察组。对照组给予接受布地奈德福莫特罗粉吸入剂治疗,观察组在使用布地奈德福莫特罗粉吸入剂治疗的基础上口服琥珀酸美托洛尔缓释片治疗,观察对比两组治疗效果。结果:观察组临床治疗效果优于对照组,观察组住院时长以及并发症的发生率低于对照组(P<0.05),差异具有统计学意义。结论:老年COPD合并冠心病史接受美托洛尔治疗,可有效缩短住院时长、用药效果明显、有效提升用药安全性,值得临床推广。 相似文献
63.
《Nutrition Clinique et Métabolisme》2016,30(2):158-162
IntroductionFor many years, nutrition of the elderly is of a special attention. The food policies wants to value the regional initiatives that can be slowed down, and new techniques of adapted food are in development. Following a tracking of malnutrition in an establishment for dependent elderly, a program of nutritional improvement was set up. It was decided to transform the dishes of the daily menu into small enriched, mixed, prehensile mouthfuls, with for objective to use the remaining capacities of the patients, to adapt the care to their rhythm, to answer their expectations and their nutritional needs.MethodThe agents of texture of the mouthfuls were adapted. Their enrichment and their presentation were specified, as well as the modalities of distribution, in order to allow an easy access as well by the patients, the nursing and the families. Cooled cupboards were used.ResultsThe residents found again the pleasure to eat by themselves, their self-respect and consequently covered better their needs. A decrease of the malnutrition prevalence was observed. Times of exchange with other establishments and a formation were set up to share this tool. Levers were identified to develop this concept under good conditions.ConclusionThe adapted enriched mouthfuls tool seems to be useful. Its application is inseparable of a voluntary multidisciplinary approach, anchored in the knowledge of the accompanied person and in the analysis of her global situation. This tool is adaptable not only in any structure welcoming dependent, old people or not, but also at home. 相似文献
64.
65.
目的:特应性皮炎的发病及治疗存在很大的异质性,在治疗方面特别强调个体化治疗,本文主要总结成年女性特应性皮炎的治疗思路和方法。方法:基于肝脾两脏的生理、病理及成年女性特应性皮炎的临床表现,深入分析其病因病机及治疗方法。结果:女性成年特应性皮炎患者常肝脾同病,肝郁脾虚湿蕴和肝郁脾虚血弱是成年女性特应性皮炎的常见证型,临床可采用疏肝健脾祛湿法和疏肝健脾养血法进行治疗。典型病例中采用肝脾同调法不但可以改善患者的皮疹,也可有效缓解瘙痒和不良情绪。结论:肝脾同调法是治疗成年女性特应性皮炎的有效方法。 相似文献
66.
阿尔茨海默病(Alzheimer’s Disease,AD)归属于中医"痴呆""呆病""健忘"等范畴,历代医家认为此病多以肾精失养,髓海空虚为主要病机,治疗多从脾、肾两脏着手,鲜有提及从胆论治。从中医学"凡土脏取决于胆"理论切入,以土脏与AD发病的关系为着眼点,并结合胆内藏精汁,助脾胃腐熟运化水谷;胆主升清降浊,疏利中土;胆内寄相火,参与腐熟水谷的生理功能和特性,阐述从胆论治AD的理论基础,以期为中医临床更加有效的防治阿尔茨海默病提供参考。 相似文献
67.
68.
69.
Ana M. Gómez Angelica Imitola Diana Henao Maira García-Jaramillo Marga Giménez Clara Viñals Bruno Grassi Mariana Torres Isabella Zuluaga Oscar Mauricio Muñoz Martin Rondón Fabián León-Vargas Ignacio Conget 《Diabetes & Metabolic Syndrome: Clinical Research & Reviews》2021,15(1):267-272
Background and aimsDespite using sensor-augmented pump therapy (SAPT) with predictive low-glucose management (PLGM), hypoglycemia is still an issue in patients with type 1 Diabetes (T1D). Our aim was to determine factors associated with clinically significant hypoglycemia (<54 mg/dl) in persons with T1D treated with PLGM-SAPT.Methodology: This is a multicentric prospective real-life study performed in Colombia, Chile and Spain. Patients with T1D treated with PLGM-SAPT, using sensor ≥70% of time, were included. Data regarding pump and sensor use patterns and carbohydrate intake from 28 consecutive days were collected. A bivariate and multivariate Poisson regression analysis was carried out, to evaluate the association between the number of events of <54 mg/dl with the clinical variables and patterns of sensor and pump use.Results188 subjects were included (41 ± 13.8 years-old, 23 ± 12 years disease duration, A1c 7.2% ± 0.9). The median of events <54 mg/dl was four events/patient/month (IQR 1–10), 77% of these events occurred during day time. Multivariate analysis showed that the number of events of hypoglycemia were higher in patients with previous severe hypoglycemia (IRR1.38; 95% CI 1.19–1.61; p < 0.001), high glycemic variability defined as Coefficient of Variation (CV%) > 36% (IRR 2.09; 95%CI 1.79–2.45; p < 0.001) and hypoglycemia unawareness. A protector effect was identified for adequate sensor calibration (IRR 0.77; 95%CI 0.66–0.90; p:0.001), and the use of bolus wizard >60% (IRR 0.74; 95%CI 0.58–0.95; p:0.017).ConclusionIn spite of using advanced SAPT, clinically significant hypoglycemia is still a non-negligible risk. Only the identification and intervention of modifiable factors could help to prevent and reduce hypoglycemia in clinical practice. 相似文献
70.